Published in Clin J Am Soc Nephrol on July 07, 2011
Cumulative patency of contemporary fistulas versus grafts (2000-2010). Clin J Am Soc Nephrol (2013) 1.57
Objectives and design of the hemodialysis fistula maturation study. Am J Kidney Dis (2013) 1.27
Re-envisioning Fistula First in a patient-centered culture. Clin J Am Soc Nephrol (2013) 1.03
The impact of an "acute dialysis start" on the mortality attributed to the use of central venous catheters: a retrospective cohort study. BMC Nephrol (2012) 0.99
Increased production of superoxide anion contributes to dysfunction of the arteriovenous fistula. Am J Physiol Renal Physiol (2012) 0.94
Catheter last, fistula not-so-first. J Am Soc Nephrol (2014) 0.87
Regional and systemic hemodynamic responses following the creation of a murine arteriovenous fistula. Am J Physiol Renal Physiol (2011) 0.86
Association between prior peripherally inserted central catheters and lack of functioning arteriovenous fistulas: a case-control study in hemodialysis patients. Am J Kidney Dis (2012) 0.85
The molecular mechanisms of hemodialysis vascular access failure. Kidney Int (2016) 0.84
Histopathology of Veins Obtained at Hemodialysis Arteriovenous Fistula Creation Surgery. J Am Soc Nephrol (2017) 0.84
New Insights into Dialysis Vascular Access: Impact of Preexisting Arterial and Venous Pathology on AVF and AVG Outcomes. Clin J Am Soc Nephrol (2016) 0.82
Case series of 5 patients with end-stage renal disease with reversible dyspnea, heart failure, and pulmonary hypertension related to arteriovenous dialysis access. Pulm Circ (2015) 0.82
Intimal Hyperplasia, Stenosis, and Arteriovenous Fistula Maturation Failure in the Hemodialysis Fistula Maturation Study. J Am Soc Nephrol (2017) 0.81
Functioning of an arteriovenous fistula requires heme oxygenase-2. Am J Physiol Renal Physiol (2013) 0.80
Candidate gene analysis of arteriovenous fistula failure in hemodialysis patients. Clin J Am Soc Nephrol (2013) 0.79
CD4(+) lymphocytes improve venous blood flow in experimental arteriovenous fistulae. Surgery (2015) 0.77
Very low protein diets supplemented with keto-analogues in ESRD predialysis patients and its effect on vascular stiffness and AVF Maturation. BMC Nephrol (2016) 0.77
c-Kit signaling determines neointimal hyperplasia in arteriovenous fistulae. Am J Physiol Renal Physiol (2014) 0.76
Balloon-assisted maturation (BAM) of the arteriovenous fistula: the good, the bad, and the ugly. Semin Nephrol (2012) 0.76
The Biology of Hemodialysis Vascular Access Failure. Semin Intervent Radiol (2016) 0.75
Dialysis Vascular Access Intervention and the Search for Biomarkers. J Am Soc Nephrol (2015) 0.75
Association of Peritonitis with Hemodialysis Catheter Dependence after Modality Switch. Clin J Am Soc Nephrol (2016) 0.75
The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications. BMC Nephrol (2015) 0.75
Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA (2008) 7.50
Functional status of elderly adults before and after initiation of dialysis. N Engl J Med (2009) 6.45
Age affects outcomes in chronic kidney disease. J Am Soc Nephrol (2007) 5.36
Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med (2007) 3.80
Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int (2002) 3.79
Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int (2002) 3.70
Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis (2010) 3.11
Vascular access and increased risk of death among hemodialysis patients. Kidney Int (2002) 3.10
Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int (2001) 2.92
Why don't fistulas mature? Kidney Int (2006) 2.89
Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol (2004) 2.66
Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol (2006) 2.47
Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int (2005) 2.45
Current management of vascular access. Clin J Am Soc Nephrol (2007) 2.44
Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int (1999) 2.42
The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis (2003) 2.30
Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis (2004) 2.28
Impact of obesity on arteriovenous fistula outcomes in dialysis patients. Kidney Int (2006) 2.24
Risk factors for early failure of native arteriovenous fistulas. Nephron Clin Pract (2005) 2.24
Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg (2002) 2.07
Balancing Fistula First with Catheters Last. Am J Kidney Dis (2007) 1.83
Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. J Vasc Surg (2003) 1.79
Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol (2008) 1.77
Fistula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol (2007) 1.75
Changes in survival among elderly patients initiating dialysis from 1990 to 1999. CMAJ (2007) 1.70
Vascular access for hemodialysis. Kidney Int (1999) 1.65
Factors associated with early failure of arteriovenous fistulae for haemodialysis access. Eur J Vasc Endovasc Surg (1996) 1.65
Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int (2003) 1.64
Dialysis fistula or graft: the role for randomized clinical trials. Clin J Am Soc Nephrol (2010) 1.47
Competing risk factor analysis of end-stage renal disease and mortality in chronic kidney disease. Am J Nephrol (2008) 1.39
Arteriovenous fistula outcomes in the era of the elderly dialysis population. Kidney Int (2005) 1.31
A meta-analysis of dialysis access outcome in elderly patients. J Vasc Surg (2007) 1.30
Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol (2004) 1.28
Predictors of successful arteriovenous fistula maturation. Am J Kidney Dis (2003) 1.22
Cardiovascular comorbidity and late referral impact arteriovenous fistula survival: a prospective multicenter study. J Am Soc Nephrol (2004) 1.14
Timing of first cannulation and vascular access failure in haemodialysis: an analysis of practice patterns at dialysis facilities in the DOPPS. Nephrol Dial Transplant (2004) 1.10
Hospital specific aspects predominantly determine primary failure of hemodialysis arteriovenous fistulas. J Vasc Surg (2007) 1.00
Brachiobasilic versus brachiocephalic arteriovenous fistula: a prospective randomized study. J Vasc Surg (2008) 0.99
Outcomes of tunneled femoral hemodialysis catheters: comparison with internal jugular vein catheters. Kidney Int (2005) 0.96
Renal replacement in end-stage renal disease patients over 75 years old. Am J Nephrol (2002) 0.93
Pre-operative radial arterial diameter predicts early failure of arteriovenous fistula (AVF) for haemodialysis. Eur J Vasc Endovasc Surg (2006) 0.92
Factors predictive of failure of Brescia-Cimino arteriovenous fistulas. Eur J Surg (2002) 0.77
Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol (2006) 4.94
The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol (2008) 4.10
Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med (2002) 3.71
Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol (2010) 3.47
Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg (2002) 2.68
The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era. J Urol (2010) 2.60
Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer. Cancer (2011) 2.58
Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation. Kidney Int (2010) 2.51
Physiology and pathophysiology of heme: implications for kidney disease. J Am Soc Nephrol (2007) 2.43
Mortality associated with nephropathy after radiographic contrast exposure. Mayo Clin Proc (2008) 2.42
Radiation therapy after radical prostatectomy: impact on metastasis and survival. J Urol (2009) 2.37
Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence. Eur Urol (2011) 2.33
Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy. PLoS One (2013) 2.31
Shock wave lithotripsy and diabetes mellitus: a population-based cohort study. Urology (2011) 2.26
MCP-1 is up-regulated in unstressed and stressed HO-1 knockout mice: Pathophysiologic correlates. Kidney Int (2005) 2.25
Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol (2009) 2.22
Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: a population-based study. Mayo Clin Proc (2005) 2.17
A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy. PLoS One (2008) 2.09
Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population. J Urol (2013) 2.07
Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood (2013) 2.05
PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression. Cancer (2007) 2.00
Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults. Clin J Am Soc Nephrol (2010) 1.91
Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol (2010) 1.89
Neoangiogenesis and the presence of progenitor cells in the venous limb of an arteriovenous fistula in the rat. Am J Physiol Renal Physiol (2007) 1.88
Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant (2011) 1.87
Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant (2003) 1.86
Phenotypic characterization of kidney stone formers by endoscopic and histological quantification of intrarenal calcification. Kidney Int (2013) 1.84
Use of a novel ultrafiltration device as a treatment strategy for diuretic resistant, refractory heart failure: initial clinical experience in a single center. J Card Fail (2006) 1.77
Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis. Am J Kidney Dis (2008) 1.77
Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2004) 1.75
Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study. Clin J Am Soc Nephrol (2006) 1.75
Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study. J Urol (2008) 1.73
Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy. J Urol (2008) 1.73
Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at mayo clinic. Clin J Am Soc Nephrol (2007) 1.68
Radical prostatectomy for prostatic adenocarcinoma: a matched comparison of open retropubic and robot-assisted techniques. BJU Int (2008) 1.64
Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery (2011) 1.64
Endothelial progenitor cells stimulate cerebrovascular production of prostacyclin by paracrine activation of cyclooxygenase-2. Circ Res (2007) 1.62
Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy. Ann Intern Med (2006) 1.61
Temporal trends in incidence of kidney stones among children: a 25-year population based study. J Urol (2012) 1.59
Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. Kidney Int (2008) 1.58
Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects. Trends Pharmacol Sci (2008) 1.56
Antigen presentation by dendritic cells in renal lymph nodes is linked to systemic and local injury to the kidney. Kidney Int (2005) 1.52
Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption. Proc Natl Acad Sci U S A (2007) 1.50
Does body mass index "dilute" the predictive property of prostate-specific antigen for tumor volume at radical prostatectomy? Urology (2011) 1.45
Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol (2010) 1.44
Serum calcium is not predictive of aggressive prostate cancer after radical prostatectomy. Urology (2010) 1.42
Risk stratification of patients with extraprostatic extension and negative lymph nodes at radical prostatectomy: identifying optimal candidates for adjuvant therapy. J Urol (2013) 1.41
Exploratory study of relationship between hospitalized heart failure patients and chronic renal replacement therapy. Nephrol Dial Transplant (2009) 1.40
Preoperative prostate specific antigen doubling time and velocity are strong and independent predictors of outcomes following radical prostatectomy. J Urol (2005) 1.38
The hyperbilirubinemic Gunn rat is resistant to the pressor effects of angiotensin II. Am J Physiol Renal Physiol (2004) 1.37
Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study. Am J Kidney Dis (2006) 1.35
A major role for carbon monoxide as an endogenous hyperpolarizing factor in the gastrointestinal tract. Proc Natl Acad Sci U S A (2003) 1.35
Outcome of patients with end-stage renal disease admitted to the intensive care unit. Mayo Clin Proc (2004) 1.35
Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke (2004) 1.34
Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota. Am J Kidney Dis (2009) 1.32
Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension. Am J Physiol Renal Physiol (2009) 1.27
Dendritic cells facilitate accumulation of IL-17 T cells in the kidney following acute renal obstruction. Kidney Int (2008) 1.27
Obesity and survival after radical prostatectomy: A 10-year prospective cohort study. Cancer (2006) 1.26
Mechanism of insulin's anabolic effect on muscle: measurements of muscle protein synthesis and breakdown using aminoacyl-tRNA and other surrogate measures. Am J Physiol Endocrinol Metab (2006) 1.24
Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection. Am J Physiol Regul Integr Comp Physiol (2011) 1.24
Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis (2004) 1.23
MCP-1 contributes to arteriovenous fistula failure. J Am Soc Nephrol (2010) 1.23
Somatostatin analog therapy for severe polycystic liver disease: results after 2 years. Nephrol Dial Transplant (2012) 1.20
Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med (2008) 1.20
Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int (2003) 1.19
Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin. Hypertension (2007) 1.18
Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxis. Ann Allergy Asthma Immunol (2008) 1.18
Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- mice. Am J Pathol (2007) 1.16
Characterization of a model of an arteriovenous fistula in the rat: the effect of L-NAME. Am J Pathol (2010) 1.15
Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol (2012) 1.15
Heme: a novel inducer of MCP-1 through HO-dependent and HO-independent mechanisms. Am J Physiol Renal Physiol (2003) 1.15
Heme activates the heme oxygenase-1 gene in renal epithelial cells by stabilizing Nrf2. Am J Physiol Renal Physiol (2002) 1.14
Hemolysis and acute kidney failure. Am J Kidney Dis (2010) 1.14
Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances. Clin J Am Soc Nephrol (2011) 1.13
Service census caps and unit-based admissions: resident workload, conference attendance, duty hour compliance, and patient safety. Mayo Clin Proc (2012) 1.12
Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease. Am J Physiol Renal Physiol (2006) 1.12
Intranasal exposure to staphylococcal enterotoxin B elicits an acute systemic inflammatory response. Shock (2006) 1.10
A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis. Cardiovasc Hematol Disord Drug Targets (2009) 1.07
Genetic deficiency of Smad3 protects the kidneys from atrophy and interstitial fibrosis in 2K1C hypertension. Am J Physiol Renal Physiol (2012) 1.05
Heme: a determinant of life and death in renal tubular epithelial cells. Am J Physiol Renal Physiol (2004) 1.05
Metastatic pulmonary calcification in a dialysis patient: case report and a review. Hemodial Int (2006) 1.05
LPS-induced murine systemic inflammation is driven by parenchymal cell activation and exclusively predicted by early MCP-1 plasma levels. Am J Pathol (2011) 1.04
Is the GPSM scoring algorithm for patients with prostate cancer valid in the contemporary era? J Urol (2007) 1.02
Increased blood flow causes coordinated upregulation of arterial eNOS and biosynthesis of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol (2005) 1.01
Does the source of death information affect cancer screening efficacy results? A study of the use of mortality review versus death certificates in four randomized trials. Clin Trials (2010) 1.01
Radical retropubic prostatectomy in immunosuppressed transplant recipients. J Urol (2008) 1.00
Determination of serum and plasma sclerostin concentrations by enzyme-linked immunoassays. J Clin Endocrinol Metab (2011) 0.99
AKI: a path forward. Clin J Am Soc Nephrol (2013) 0.98
TGF-beta1 stimulates monocyte chemoattractant protein-1 expression in mesangial cells through a phosphodiesterase isoenzyme 4-dependent process. Am J Physiol Cell Physiol (2005) 0.98
Smooth muscle progenitor cells in vascular disease. Trends Cardiovasc Med (2004) 0.98
Outcome of patients with low ejection fraction undergoing coronary artery bypass grafting: renal function and mortality after 3.8 years. Circulation (2006) 0.98
Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and blood. Clin Chem (2012) 0.97
Intermittent hemodialysis versus continuous renal replacement therapy for acute renal failure in the intensive care unit: an observational outcomes analysis. J Intensive Care Med (2008) 0.97
The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy. J Urol (2008) 0.96
Increased production of superoxide anion contributes to dysfunction of the arteriovenous fistula. Am J Physiol Renal Physiol (2012) 0.94
Inhibition of p38 MAPK attenuates renal atrophy and fibrosis in a murine renal artery stenosis model. Am J Physiol Renal Physiol (2013) 0.94